Hypertrophic Cardiomyopathy for Professionals

Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder defined by left ventricular (LV) hypertrophy that cannot be explained by another cardiac or systemic disease. Learning more about HCM will ensure you are better able to discuss its impact with your patients.

HCM Videos on demand graphic

Patients whose lives have been restricted by HCM may be able to reduce symptoms and comorbidities. Watch this video series to increase your knowledge.

Watch Hypertrophic Cardiomyopathy Videos
HCM Podcasts

From diagnosis to management and beyond, these HCM podcasts will help you communicate best with your patients.

Listen to Hypertrophic Cardiomyopathy Podcasts
HCM Clinical Review

Learn more on recognizing and evaluating the pathophysiology of hypertrophic cardiomyopathy (HCM) with AHA’s Hypertrophic Cardiomyopathy Clinical Review.

Launch the HCM Clinical Review

What’s New When It Comes to Diagnosing and Treating Hypertrophic Cardiomyopathy Patients

Watch this video to find out from leading experts as they discuss the impact of the 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy. Learn the latest on diagnostic and treatment options for patients, including new treatments on the horizon. Advance a new standard of care for patients with HCM. 

HCM Patients

In speaking with patients who complain of symptoms consistent with HCM, ask if family members have been diagnosed with HCM, or if there is a family history of sudden cardiac arrest or died due to an unknown cardiovascular disease. When patients present with symptoms such as fatigue, fainting, shortness of breath, chest pain or heart palpitations without a known cause, suspect and test for HCM. With your help, patients whose lives have been restricted due to HCM may be able to reduce symptoms and comorbidities.

Patients can learn more at heart.org/HCM
wife straightening her husband's tie

A thumbnail image of the Hypertrophic Cardiomyopathy infographic in collaboration with HCMADownload this free poster developed in collaboration with HCMA

Print this poster as a discussion guide for conversations with patients. As you talk with your patients use this as an educational tool. Early detection and disease/symptom management may help reduce some of the consequences of HCM and improve outcomes.

With your help, patients whose lives have been restricted due to HCM may be able to reduce symptoms and comorbidities.

Free HCM Infographic Poster (PDF)
White couple walking their dog and smiling.

Hypertrophic Cardiomyopathy Roundtable Report

Recognizing the importance of confronting HCM and the broad range of individuals working on various aspects of the disease, the AHA has hosted roundtable discussions. This report identifies steps needed to achieve an "ideal state" for HCM patients.

Read the HCM Roundtable Report (PDF)
illustration of golden glowing heart in blue chest

Hypertrophic Cardiomyopathy - Sudden Cardiac Death Risk Calculator

This calculator is for use in calculating risk of sudden cardiac death in patients with HCM using the 2020 AHA/ACC Guidelines for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy.

Access the HCM SCD Risk Calculator

Guidelines-on-the-Go

Photo of female healthcare professional looking at a smart phone. Banner says, "Guidelines On The Go, AHA science at your fingertips"

The Guidelines-on-the-Go App features the 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy, plus so much more.

For iOS For Android

Guidelines and Articles

American Heart Association's Hypertrophic Cardiomyopathy Initiative is sponsored by Bristol Myers Squibb.